The transfer of knowledge and technology from Big Science centers can have a real impact on various fields of business, industry and science. Among the fields in which the achievements of centers such as CERN are used, there is also medicine. This is evidenced by the HEV (High Energy Ventilator), a high-quality, versatile, cheap-to-produce respirator, the design and prototype of which was developed during the COVID-19 pandemic at CERN.
The High Energy Ventilator (HEV) project was born during the COVID-19 pandemic to design and prototype a versatile, high-quality, low-cost medical ventilator. It intends to provide long term alveolar ventilation support to patients, in or out of intensive care, for intubated and non-invasive cases. Clinical advice has guided the main choices during the design process, providing further insights to the COVID-19 official emergency guidelines from the MHRA, WHO and AAMI.
In 2020, UK Research and Innovation (UKRI), through the Global Challenges Research Fund, awarded funding to redesign the HEV for use in low- and middle-income countries. The High Performance Low Cost Ventilator (HPLV), based on the HEV prototype, relies less on compressed gases and mains electricity supply—making it more suitable for a variety of challenging settings in regions where optimal conditions might not be available.
HEV technology can be used by all stakeholders around the world. Licenses for its use can be obtained by any institution or company that submits the appropriate documentation.